CG CLASSIFIEDS
We are looking for a second fellowship-trained Geriatrician to join our amazing rural Upstate New York community.
Supplements & Special Projects
First Report®
First Report®
American Urological Association Annual Meeting
San Francisco, CA; May 29-June 3, 2010
Effect of Dutasteride on the Detection of Prostate Cancer in Men with BPH in the CombAT Study
San Francisco, CA—The REduction by DUtasteride in prostate Cancer Events (REDUCE) study showed that dutasteride treatment resulted in 23% relative risk reduction (RRR) in biopsydetectable prostate cancer (PCa) vs. placebo in men with elevated prostate-specific antigen (PSA) and a negative baseline biopsy, who underwent scheduled biopsies at 2 and 4 years. The CombAT benign prostatic hyperplasia (BPH) study provides an opportunity to evaluate the rates of PCa in men treated with dutasteride in a typical clinical setting, with annual PSA and digital rectal examination (DRE) screening and prostate biopsies undertaken only for-cause.
First Report®
American College of Cardiology 59th Annual Scientific Session
March 14-16, 2010; Atlanta, GA
Ticagrelor Reduces Mortality as Compared with Clopidogrel After CABG Surgery
Atlanta, GA—Patients with acute coronary syndrome (ACS) who had coronary artery bypass graft (CABG) surgery had lower death rates from any cause or from cardiovascular causes when treated with the novel antiplatelet agent ticagrelor versus standard clopidogrel. The improvement in mortality with ticagrelor was achieved despite major bleeding that was similar in the two treatment arms. These findings from an exploratory subgroup analysis of the PLATO (PLATelet Inhibition and Patient Outcomes) trial, presented at a late-breaking clinical trials session during the ACC meeting, surprised some investigators.
First Report®
American Association for Geriatric Psychiatry 2010 Annual Meeting
Savannah, GA; March 5-8, 2010
Poster
Effects of Rivastigmine Transdermal Patch on Cognitive Ability in Patients with Mild-to-Moderately Severe AD
Savannah, GA—In their study examining the specific effects of rivastigmine on individual Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) items and cognitive domain scores, George T. Grossberg, MD, St. Louis University School of Medicine, St. Louis, MO, and colleagues found that the rivastigmine patch is associated with improved cognitive
American Epilepsy Society 63rd Annual Meeting
Poster
Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures
Boston, MA—The purpose of this study, presented as a poster at the annual AES meeting, was to examine the long-term safety of lacosamide (LCM) for partial-onset seizures based on all available data from Phase II-III double-blind and open-label extension trials. William Rosenfeld, MD, of the Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, and colleagues found that long-term LCM treatment was generally well tolerated in their analysis of 1327 patients exposed to
American Academy of Pain Medicine 2010 Annual Meeting
Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Seniors and Younger Patients with Hand Osteoarthritis
San Antonio, TX—Roy D. Altman, MD, University of California-Los Angeles, and colleagues examined the safety and efficacy of diclofenac sodium 1% gel (DSG) in patients age < 65 and ≥ 65 years with hand osteoarthritis (OA). Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Three hundred eighty-five adults with radiographically verified hand OA were randomized t
First Report®
American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting
Philadelphia, PA; October 17-21, 2009
_______________________
Sustained Response in Early Rheumatoid Arthritis with Abatacept
Philadelphia, PA—Two-year data from the AGREE (Abatacept Study to Gauge Remission and Joint Damage Progression in Methotrexate-Naïve Patients with Early Erosive Rheumatoid Arthritis) trial show that patients treated with abatacept in combination with methotrexate (MTX) achieved sustained low disease activity scores at 24 months. Results of
First Report®
American Heart Association Scientific Sessions 2009
November 14-18, 2009
Orlando, FL
Extended-Release Niacin Superior to Ezetimibe in Inducing Regression of Atherosclerosis in At-Risk Patients
Orlando, FL—Extended-release niacin was superior to ezetimibe when added to a statin for inducing regression of atherosclerosis, according to results of the Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6: HDL and LDL Treatment Strategies in Atherosclerosis (ARBITER6-HALTS) study. The study was presented at the 2009 Scientific Sessions
First Report®
American Heart Association Scientific Sessions 2009
November 14-18, 2009
Orlando, FL
______________________________
Investigational Left Ventricular Assist Device Prolongs Life in Advanced Heart Failure as Compared to FDA-Approved Pulsatile-Flow Device
Orlando, FL—A second-generation left ventricular assist device (LVAD) called HeartMate II achieved superior outcomes as compared to its predecessor, HeartMate XVE, in patients with advanced heart failure (HF) who were ineligible for heart transplantation. In the HeartMate II Destination Therapy Clinical Trial, 2-
First Report®
American Academy of Family Physicians
2009 Scientific Assembly
October 14-17, 2009; Boston, MA
Screening and Preventive Care in the Elderly
Boston, MA—Aubrey L. Knight, MD, FAAFP, presented a session at the American Academy of Family Physicians (AAFP) meeting on screening and preventive care in the elderly. Challenges for clinicians include the fact that most trials exclude patients over age 75, data from trials are not necessarily applicable to individual patients, and trials do not address how individual characteristics affect the benefit versus harm calculation
First Report®: 31st Annual Meeting of the American Society for Bone and Mineral Research Denver, CO; September 11-15, 2009
Decreased Serum Vitamin B12 Concentration is Associated With Greater Fall Risk Among Older Disabled Women: The Women’s Health and Aging Study
Denver, CO—Robert McLean, DSc, Hebrew SeniorLife Institute for Aging Research and Harvard Medical School, Boston, MA, and colleagues examined the associations of serum concentrations of folate, vitamin B12, methylmalonic acid (MMA) and homocysteine with the risk of falling among older disabled women participating in the Women’s Health and Aging Study. Results presented at the ASBMR annual meeting suggest that low vitamin B12 status may
Clinical Geriatrics Blogs
Coming in Future Issues of Clinical Geriatrics
Series: Diabetes in the Elderly
Series: Cancer in Older Adults
First Report® Conference Coverage: American Academy of Neurology, American Diabetes Association, 2010 Digestive Disease Week
Assessment and Classification of Pain in the Elderly Patient
Pharmacologic Management of Pain in Older Patients
Miscellaneous Pain Syndromes in Older Adults
Nonhernia Causes of Inguinal Pain in the Elderly
